Patent ID: 11932630
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 16:
17. A combination comprising a therapeutically effective amount of a compound according to claim 1 or a pharmaceutically acceptable salt thereof and one or more therapeutically active co-agents selected from a croup consisting of a COX inhibitor, a Cysteinyl-Leukotriene Receptor antagonist, a leukotriene C4 synthase (LTC4S) inhibitor, a NLRP3 inhibitor, a statin, sulfasalazine, Mesalamine, a calcineurin inhibitor, a mTOR inhibitor, an ascomycin having immunosuppressive properties, corticosteroids, cyclophosphamide; azathioprene; methotrexate; leflunomide; mizoribine; mycophenolic acid or salt; mycophenolate mofetil and IL-1beta inhibitor.